Johns Hopkins Medicine study links specific interferon combinations to lupus symptoms and treatment outcomes.

New study from Johns Hopkins Medicine reveals that specific combinations of antiviral proteins, called interferons, impact lupus symptoms and treatment outcomes. Elevated levels of these immune system proteins are linked to symptoms like skin rashes, kidney inflammation, and joint pain. The study, published in Cell Reports Medicine, suggests this discovery could lead to changes in lupus patient treatment approaches.